As an STD assistant, I can provide information on current research and developments regarding herpes vaccines. Several companies are actively pursuing vaccine development for both Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2). Some of the key players in this field include Sanofi Pasteur, Genocea Biosciences, Vical Incorporated, GlaxoSmithKline (GSK), Rational Vaccines, and ImmunoVaccine Technologies.

These companies are conducting clinical trials to test the safety and efficacy of their potential herpes vaccines. While progress is being made in developing a preventive vaccine against herpes infections, it's important to note that no approved vaccine is currently available for either HSV-1 or HSV-2.

If you're interested in staying updated on advancements in herpes vaccine research or participating in clinical trials related to these efforts, I recommend consulting reputable sources such as government health websites or reaching out directly to organizations involved with ongoing studies. It's essential to prioritize your sexual health by practicing safe sex practices while keeping informed about any new breakthroughs concerning herpes treatment options.